In silico modeling has become an essential part of our research. When developing the methodology to measure drug release we became aware of the limited knowledge on key aspects affecting the performance of nanomedicines. To support the development of novel in vitro methods we use physiologically-based pharmacokinetics modeling (PBPK) modeling and provide our models to a wider audience on this website.

 

Models 4 Education

Simulation of pharmacokinetics after peroral administration of a single dose assuming dissolution to be rate-limiting for absorption

 

Models 4 Research

In Silico Model to Conduct an Environmental Risk Assessment of Fenofibrate